CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Update

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) saw a significant growth in short interest in February. As of February 27th, there was short interest totaling 13,626 shares, a growth of 359.4% from the February 12th total of 2,966 shares. Based on an average daily trading volume, of 22,146 shares, the short-interest ratio is presently 0.6 days. Based on an average daily trading volume, of 22,146 shares, the short-interest ratio is presently 0.6 days.

CSPC Pharmaceutical Group Price Performance

OTCMKTS CSPCY traded down C$0.16 during trading on Wednesday, reaching C$4.57. The company’s stock had a trading volume of 344 shares, compared to its average volume of 5,090. The firm has a fifty day moving average of C$4.92 and a 200 day moving average of C$4.64. CSPC Pharmaceutical Group has a one year low of C$2.32 and a one year high of C$5.83.

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.